Answers are grounded in this paper and cite their sources.
Review examines coating advancements in orthopedic implants, highlighting benefits and adoption challenges.
Orthopedic implant technology continues to evolve through advances in surface engineering, particularly in the development of coating technologies designed to enhance implant integration, reduce infection, and mitigate inflammatory responses. Despite a vast array of literature and attention, growing scientific evidence does not support a clinically significant role for metal hypersensitivity in orthopedic implants. Instead, research has shifted to emerging surface treatments such as titanium nitride, oxide ceramics, and antimicrobial polymers that are engineered to improve osseointegration and resist microbial colonization. Coatings that incorporate non-eluting antimicrobial agents, smart stimuli-responsive materials, and wear-resistant ceramics show promising preclinical results, with some advancing to clinical trials. As these technologies mature, they may significantly reduce complications traditionally attributed to material biocompatibility and so-called metal allergy. This review examines recent literature on emerging advances in surface coating technology for orthopedic implants and the obstacles these technologies face in the journey towards clinical adoption. Hybrid implant modifications that target bacterial biology as well as colonization chemistry appear to be the next evolution of orthopedic implant coatings. Future research should prioritize validating long-term outcomes, optimizing coating durability, conducting cost-analysis surveys, and exploring pathways toward improved manufacturing.
No takes yet. Share an insight, caveat, or question.
Aboaziza et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: